203 related articles for article (PubMed ID: 1565464)
1. SCL is coexpressed with GATA-1 in hemopoietic cells but is also expressed in developing brain.
Green AR; Lints T; Visvader J; Harvey R; Begley CG
Oncogene; 1992 Apr; 7(4):653-60. PubMed ID: 1565464
[TBL] [Abstract][Full Text] [Related]
2. Regulation of lineage restricted haemopoietic transcription factors in cell hybrids.
Murrell AM; Green AR
Oncogene; 1995 Feb; 10(4):631-9. PubMed ID: 7862440
[TBL] [Abstract][Full Text] [Related]
3. SCL and related hemopoietic helix-loop-helix transcription factors.
Green AR; Begley CG
Int J Cell Cloning; 1992 Sep; 10(5):269-76. PubMed ID: 1453013
[TBL] [Abstract][Full Text] [Related]
4. Discordant regulation of SCL/TAL-1 mRNA and protein during erythroid differentiation.
Murrell AM; Bockamp EO; Göttgens B; Chan YS; Cross MA; Heyworth CM; Green AR
Oncogene; 1995 Jul; 11(1):131-9. PubMed ID: 7624120
[TBL] [Abstract][Full Text] [Related]
5. Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1.
Zeuner A; Eramo A; Testa U; Felli N; Pelosi E; Mariani G; Srinivasula SM; Alnemri ES; Condorelli G; Peschle C; De Maria R
Cell Death Differ; 2003 Aug; 10(8):905-13. PubMed ID: 12867998
[TBL] [Abstract][Full Text] [Related]
6. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.
Lecointe N; Bernard O; Naert K; Joulin V; Larsen CJ; Romeo PH; Mathieu-Mahul D
Oncogene; 1994 Sep; 9(9):2623-32. PubMed ID: 8058326
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
8. Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements.
Göttgens B; McLaughlin F; Bockamp EO; Fordham JL; Begley CG; Kosmopoulos K; Elefanty AG; Green AR
Oncogene; 1997 Nov; 15(20):2419-28. PubMed ID: 9395238
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system.
Visvader J; Begley CG; Adams JM
Oncogene; 1991 Feb; 6(2):187-94. PubMed ID: 2000219
[TBL] [Abstract][Full Text] [Related]
10. Chromatin immunoselection defines a TAL-1 target gene.
Cohen-Kaminsky S; Maouche-Chrétien L; Vitelli L; Vinit MA; Blanchard I; Yamamoto M; Peschle C; Roméo PH
EMBO J; 1998 Sep; 17(17):5151-60. PubMed ID: 9724651
[TBL] [Abstract][Full Text] [Related]
11. Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis.
Labbaye C; Valtieri M; Barberi T; Meccia E; Masella B; Pelosi E; Condorelli GL; Testa U; Peschle C
J Clin Invest; 1995 May; 95(5):2346-58. PubMed ID: 7738198
[TBL] [Abstract][Full Text] [Related]
12. Induced myeloid differentiation of K562 cells with downregulation of erythroid and megakaryocytic transcription factors: a novel experimental model for hemopoietic lineage restriction.
Green AR; Rockman S; DeLuca E; Begley CG
Exp Hematol; 1993 Apr; 21(4):525-31. PubMed ID: 8462662
[TBL] [Abstract][Full Text] [Related]
13. SCL expression at critical points in human hematopoietic lineage commitment.
Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
[TBL] [Abstract][Full Text] [Related]
14. Reduction of DNA binding activity of the GATA-1 transcription factor in the apoptotic process induced by overexpression of PU.1 in murine erythroleukemia cells.
Yamada T; Kihara-Negishi F; Yamamoto H; Yamamoto M; Hashimoto Y; Oikawa T
Exp Cell Res; 1998 Nov; 245(1):186-94. PubMed ID: 9828115
[TBL] [Abstract][Full Text] [Related]
15. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1.
Pevny L; Simon MC; Robertson E; Klein WH; Tsai SF; D'Agati V; Orkin SH; Costantini F
Nature; 1991 Jan; 349(6306):257-60. PubMed ID: 1987478
[TBL] [Abstract][Full Text] [Related]
16. The SCL transcription factor and differential regulation of macrophage differentiation by LIF, OSM and IL-6.
Begley CG
Stem Cells; 1994; 12 Suppl 1():143-9; discussion 149-51. PubMed ID: 7696958
[TBL] [Abstract][Full Text] [Related]
17. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH
Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215
[TBL] [Abstract][Full Text] [Related]
18. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles.
Tsuyuoka R; Takahashi T; Suzuki A; Sasaki Y; Nakamura K; Fukumoto M; Ohmori K; Ohno Y; Nakao K
Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248
[TBL] [Abstract][Full Text] [Related]
19. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells.
Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S
Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of the distal, but not of the proximal, Gata1 transcripts during differentiation of primary erythroid cells.
Vannucchi AM; Linari S; Lin CS; Koury MJ; Bondurant MC; Migliaccio AR
J Cell Physiol; 1999 Sep; 180(3):390-401. PubMed ID: 10430179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]